Sisters Fight NHS Over Freidrich's Ataxia Treatment
Key Highlights
- Sisters with life-limiting condition take NHS to court for better treatment options.
- NHS faces judicial review over handling of Freidrich's Ataxia cases.
- Sisters seek changes to treatment options for people with Freidrich's Ataxia.
Sisters Olivia Dews and Charlotte Casey, both diagnosed with Freidrich's Ataxia, a life-limiting neurological condition, are taking the NHS to court in a bid to secure better treatment options for others with the condition.
The sisters, who have been living with the condition for several years, claim that the NHS has failed to provide them with adequate care and support. They are seeking a judicial review of the NHS's handling of their cases and are calling for changes to be made to the treatment options available for people with Freidrich's Ataxia.
Freidrich's Ataxia is a rare genetic disorder that affects the nervous system and can cause progressive damage to the brain and spinal cord. It is estimated that there are around 1,000 people living with the condition in the UK. With many more affected by it worldwide.
Read More: New Super Flu Vaccine Rollout Begins as NHS Regroups for Winter Health Surge
The sisters' case is the first of its kind to be taken to court in the UK. And it is expected to have significant implications for the NHS and the treatment of people with Freidrich's Ataxia.
The sisters are currently awaiting the outcome of their judicial review, which is expected to be heard in the coming months. If successful, their case could lead to changes being made to the NHS's treatment options for people with Freidrich's Ataxia.
The NHS has stated that it is committed to providing the best possible care for people with Freidrich's Ataxia. However, the sisters claim that this has not been the case in their own experiences.
Also Read: NHS Rolls Out Martha's Rule to All A&E Departments in England
Earl Spencer, the brother of Princess Diana, has also spoken out about the need for better treatment options for people with Freidrich's Ataxia. He has called for more research to be conducted into the condition and for greater support to be provided to those affected by it.
He has used his platform to raise awareness about the condition and to support the sisters in their fight for better treatment options.
The sisters' case is a significant development in the fight for better treatment options for people with Freidrich's Ataxia. It is a proof to the power of advocacy and the importance of speaking out for those who need it most.
What's Your Reaction?
Like
Dislike
Love
1
Funny
2
Wow
Sad
Angry
2
Comments (0)